Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Navarixin in Psoriasis
NCT00684593Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2007
- Primary completion
- Oct 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of navarixin in Psoriasis vulgaris (PV), sponsored by Merck & Co.. Started Jun 2007; status: completed.
02
Drugs
navarixin
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT00684593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00684593.